Our health-tech predictions for 2021
Over at OMERS Ventures, we’ve been thinking a lot about what 2021 will bring. First and foremost, we hope it’s a better year for all of you than the dreaded 2020. Fortunately, there’s lots of reasons for optimism, particularly with the rollout of the vaccine.
But what’s next for the health care industry specifically?
This week, my colleague Michael Yang and I sat down to hash out our predictions. Some relate to health-tech, and others are more in the realm of policy/payer trends. We also gut-checked our ideas with a range of experts in the space, and asked for their thoughts. I’ll warn you ahead of time that this newsletter will not be entirely rosy. So if you’re inclined, feel free to skip the bad news at the bottom!
About the author
Christina Farr
Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.
New York City